Article Information
History
- June 9, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Elke Wollants1,*,†,
- Els Keyaerts1,2,*,
- Lize Cuypers3,*,
- Mandy Bloemen1,
- Marijn Thijssen1,
- Sien Ombelet3,4,
- Joren Raymenants4,
- Kurt Beuselinck3,
- Lies Laenen3,
- Lore Budts2,
- Bram Pussig5,
- Katrien Lagrou3,4,
- Marc Van Ranst1,3,* and
- Emmanuel André2,3,4,*
- 1KU Leuven, Rega Institute, Department of Microbiology, Immunology and Transplantation, Laboratory of Clinical and Epidemiological Virology, Leuven, Belgium
- 2University Hospitals Leuven, Department of Laboratory Medicine, COVID-19 federal testing platform, Leuven, Belgium
- 3University Hospitals Leuven, Department of Laboratory Medicine, National Reference Center for Respiratory Pathogens, Leuven, Belgium
- 4KU Leuven, Department of Microbiology, Immunology and Transplantation, Laboratory of Clinical Microbiology, Leuven, Belgium
- 5KU Leuven, Department of Public Health and Primary Care, Academic Center for General Practice, Leuven, Belgium
- ↵†Corresponding author: elke.wollants{at}kuleuven.be (Phone: +3216321341)
↵* These authors contributed equally to this article
Posted June 09, 2022.
Environmental circulation of adenovirus 40/41 and SARS-CoV-2 in the context of the emergence of acute hepatitis of unknown origin
